Arylamine N-acetyltransferases – of mice, men and microorganisms
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 22 (3) , 140-146
- https://doi.org/10.1016/s0165-6147(00)01639-4
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- N-acetyltranferase NAT1 and NAT2 genotypes and lung cancer riskPharmacogenetics, 1998
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Functional polymorphism of the human arylamine JV-acetyltransferase type 1 gene caused by C190T and G560A mutationsPharmacogenetics, 1998
- A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid.Journal of Medical Genetics, 1997
- Evidence for arylamine N-acetyltransferase activity in the bacterium Helicobacter pyloriToxicology Letters, 1997
- Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumoursCytogenetic and Genome Research, 1997
- ACCELERATED PAPER: Lack of association between the polyadenylation polymorphism in the NATl (acetyltransferase 1) gene and colorectal adenomasCarcinogenesis: Integrative Cancer Research, 1996
- Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variantsPharmacogenetics, 1992
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960